Wells Fargo (NYSE:WFC) analyst Wells Fargo maintained a Hold rating on Tabula Rasa HealthCare (NASDAQ:TRHC) on Wednesday, setting a price target of $46, which is approximately 7.28% below the present share price of $49.61.
expects Tabula Rasa HealthCare to post earnings per share (EPS) of -$0.68 for the third quarter of 2020.
The current consensus among 8 TipRanks analysts is for a Strong Buy rating of shares in Tabula Rasa HealthCare, with an average price target of $63.25.
The analysts price targets range from a high of $83 to a low of $46.
In its latest earnings report, released on 03/31/2020, the company reported a quarterly revenue of $72.83 million and a net profit of -$12.49 million. The company's market cap is $1.12 billion.
According to TipRanks.com, Wells Fargo analyst Wells Fargo is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 11.3% and a 62.34% success rate.
Tabula Rasa Healthcare, Inc. engages in the development of pharmaceutical software that optimizes medication regimens. It offers cloud-based applications, such as EireneRx and MedWise Advisor. The company was founded by Calvin H. Knowlton and Orsula V. Knowlton in April 2009 and is headquartered in Moorestown, NJ.